Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer

Acta Oncologica

Volumn 49, Issue 7, 2010, Pages 978-983

  Haack, Søren ^a   Pedersen, Erik Morre ^a   Jespersen, Sune N ^a   Kallehauge, Jesper F ^a   Lindegaard, Jacob Christian ^a   Tanderup, Kari ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; HUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TUMOR VOLUME; UTERINE CERVIX CANCER;

BRACHYTHERAPY; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; DOSE FRACTIONATION; FEMALE; GUIDELINES AS TOPIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MODELS, THEORETICAL; NEOPLASM STAGING; ORGAN SIZE; RADIATION DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 77956599968     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.500619     Document Type: Article

References (36)

1. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828-836
2. Gibbs P, Liney GP, Pickles MD, Zelhof B, Rodrigues G, Turnbull LW. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol 2009;44:572-576
3. Xu J, Humphrey PA, Kibel AS, Snyder AZ, Narra VR, Ackerman JJ, et al. Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med 2009;61:842-850
4. Groenendaal G, Moman MR, Korporaal JG, van Diest PJ, van VM, Philippens ME, et al. Validation of functional imaging with pathology for tumor delineation in the prostate. Radiother Oncol 2010;94:145-150
5. Le BD. Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 1995;8:375-386
6. Hamstra DA, Galban CJ, Meyer CR, Johnson TD, Sundgren PC, Tsien C, et al. Functional diffusion map as an early imaging biomarker for high-grade glioma: Correlation with conventional radiologic response and overall survival. J Clin Oncol 2008;26:3387-3394
7. Ellingson BM, Malkin MG, Rand SD, Connelly JM, Quinsey C, LaViolette PS, et al. Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging 2010;31:538-548
8. Korporaal JG, van den Berg CA, Groenendaal G, Moman MR, van VM, van Der Heide UA. The use of probability maps to deal with the uncertainties in prostate cancer delineation. Radiother Oncol 2010;94:168-172
9. Harry VN, Semple SI, Gilbert FJ, Parkin DE. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 2008;111:213-220
10. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: A biomarker for treatment response in oncology. J Clin Oncol 2007;25:4104-4109 (Pubitemid 47495868)
11. Nilsen L, Fangberget A, Geier O, Olsen DR, Seierstad T. Diffusion-weighted magnetic resonance imaging for pre-treatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol 2010;49:354-360
12. Song I, Kim CK, Park BK, Park W. Assessment of response to radiotherapy for prostate cancer: Value of diffusion-weighted MRI at 3T. AJR Am J Roentgenol 2010;194: W477-W482.
13. Padhani AR, Khan AA. Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy. Target Oncol 2010;5:39-52.
14. Vandecaveye V, Dirix P, De KF, Op de BK, Vander P, V, Roebben I, et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010 (in press).
15. Tanderup K, Nielsen SK, Nyvang GB, Pedersen EM, Rohl L, Aagaard T, et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol 2010;94:173-180
16. Haie-Meder C, Pötter R, Van LE, Briot E, De BM, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235-245
17. De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van LE. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2008;88:217-226
18. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachyther-apy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:756-764
19. Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRI-based treatment planning in intracavitary brachy-therapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005;62:901-911
20. Assenholt MS, Petersen JB, Nielsen SK, Lindegaard JC, Tanderup K. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol 2008;47:1337-1343
21. Dimopoulos JC, Potter R, Lang S, Fidarova E, Georg P, Dorr W, et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachy-therapy. Radiother Oncol 2009;93:311-315
22. Pötter R, Kirisits C, Fidarova EF, Dimopoulos JC, Berger D, Tanderup K, et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008;47:1325-1336
23. Pötter R, Haie-Meder C, Van LE, Barillot I, De BM, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67-77.
24. Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: Comparison with the normal uterine cervix. Eur Radiol 2005;15:71-78
25. Payne GS, Schmidt M, Morgan VA, Giles S, Bridges J, Ind T, et al. Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer. Gynecol Oncol 2010;116:246-252
26. Charles-Edwards EM, Messiou C, Morgan VA, De Silva SS, McWhinney NA, Katesmark M, et al. Diffusion-weighted imaging in cervical cancer with an endovaginal technique: Potential value for improving tumor detection in stage Ia and Ib1 disease. Radiology 2008;249:541-550
27. McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA. Diffusion-weighted MRI in cervical cancer. Eur Radiol 2008;18:1058-1064
28. Kallehauge JF, Tanderup K, Haack S, Nielsen T, Fokdal L, Lindegaard JC, et al. Apparent diffusion coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used. Acta Oncol 2010;49:1017-1022
29. Sasaki M, Yamada K, Watanabe Y, Matsui M, Ida M, Fujiwara S, et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: A multivendor, multi-institutional comparison study. Radiology 2008;249:624-630
30. Ogura A, Hayakawa K, Miyati T, Maeda F. Imaging parameter effects in apparent diffusion coefficient determination of magnetic resonance imaging. Eur J Radiol 2009.
31. Dimopoulos JC, Schirl G, Baldinger A, Helbich TH, Potter R. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009;185:282-287
32. Mayr NA, Wang JZ, Zhang D, Grecula JC, Lo SS, Jaroura D, et al. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer. Int J Radiat Oncol Biol Phys 2010;77:502-508
33. Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: The Quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 2005;53:1432-1440
34. Yablonskiy DA, Bretthorst GL, Ackerman JJ. Statistical model for diffusion attenuated MR signal. Magn Reson Med 2003;50:664-669
35. Ostergaard NK, de Senneville BD, Elstrom UV, Tanderup K, Sorensen TS. Acceleration and validation of optical flow based deformable registration for image-guided radiotherapy. Acta Oncol 2008;47:1286-1293
36. Groenendaal G, van den Berg CA, Korporaal JG, Philippens ME, Luijten PR, van VM, et al. Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients. Radiother Oncol 2010;95:185-190